Abstract library

10 results for "Vélez".
#103 From hormone dependent solid breast carcinoma to primary neuroendocrine carcinoma: a case report
Introduction: Primary neuroendocrine carcinoma of the breast is an extremely rare tumor with incidence of 0.27-0.5%.
Conference: 7th Annual ENETS Conference (2010)
Category: Clinical
Presenting Author: Dr Djuro P Macut
Authors:
#117 Synchronous appendiceal neuroendocrine carcinoma and mucinous cystadenocarcinoma: a case report
Introduction: Appendiceal tumors with histological features of both carcinoids and adenocarcinomas are very rare. Carcinomas of the appendix are usually mucinous adenocarcinomas with a tendency to produce peritoneal pseudomyxoma and without metastatic spread until late in the disease course. Carcinoid tumors of the appendix are a common incidental finding.
Conference: 7th Annual ENETS Conference (2010)
Category: Clinical
Presenting Author: Dr Sanja Ognjanovic
Authors:
#522 Effects of Transarterial Chemoembolization of Liver Metastases from Neuroendocrine Tumors on Clinical Outcome
Introduction: Trans-catheter arterial chemoembolization (TACE) is a method of treatment of non-resectable liver metastases from neuroendocrine tumors (NET) which provides control of clinical symptoms and tumor growth.
Conference: 9th Annual ENETS Conference (2012)
Category: Clinical
Presenting Author: Dr Sanja Ognjanovic
Authors:
#673 MEN-1: Difficulties in Diagnosis and Therapeutic Dilemmas
Introduction: MEN1 is rare, and the most common mode of presentation is in previously identified kindred, but may be the propositus of a new kindred or a sporadic case.
Conference: 10th Annual ENETS Conference (2013)
Category: Basic Science - mTOR and other pathways, signalling, receptors
Presenting Author: Joana Saraiva
Authors:
#785 Efficacy of Transarterial Chemoembolization of Liver Metastases from Neuroendocrine Tumors
Introduction: Most patients with neuroendocrine tumors present with liver involvement at the time of diagnosis. Transarterial chemoembolization (TACE) is a method of treatment of non-resectable liver metastases which is effective in the control of symptoms and tumor growth.
Conference: 10th Annual ENETS Conference (2013)
Category: PRRT-Ablative therapies-Endoscopic treatment
Presenting Author: dr Sanja Ognjanovic
Authors:
#1016 Adrenal Tumors in Patients with Pancreatic Neuroendocrine Tumors
Introduction: The coexistence of adrenal tumors (AT) in patients with pancreatic neuroendocrine tumors (PNETs) has not been extensively studied.
Conference: 11th Annual ENETS Conference (2014)
Category: ...none of the below
Presenting Author: Bojana Popovic
Authors:
Keywords: PNET, adrenal, tumor
#1018 Transarterial Chemoembolization for Unresectable Liver Neuroendocrine Metastases
Introduction: Most patients with neuroendocrine tumors (NETs) present with liver involvement at the time of diagnosis. Trans-catheter arterial chemoembolization (TACE) is a method of treatment of non-resectable liver metastases.
Conference: 11th Annual ENETS Conference (2014)
Category: PRRT-Ablative therapies-Endoscopic treatment
Presenting Author: Sanja Ognjanovic
Authors:
#1735 Follow-Up in Neuroendocrine Neoplasms: Can Chromogranin A Be the Cofounder?
Introduction: Chromogranin A continues to be one of the most valuable markers for neuroendocrine tumors (NETs) however, it has several limitations.
Conference: 14th Annual ENETS conference (2017)
Category: Clinical cases/reports
Presenting Author: Dr Diana Martins
Authors:
#2120 One Year Experience with Lutetium-DOTATATE for Disseminated NETs in the Gregorio Marañon Hospital
Introduction: The main curative therapy for NET is surgical resection when the disease is localized. But high percentage of patients is diagnosed with advanced disseminated disease and the peptide receptor radionuclide therapy (PRRT) with somatostatin analogs (SSA) is an emerging effective treatment.
Conference: 15th Annual ENETS conference (2018)
Category: Nuclear Medicine - Imaging and Therapy (PRRT)
Presenting Author: Doctor Maria Picallo
Authors:
#2295 Results of Liver Transplantation in Patients with Neuroendocrine Tumors
Introduction: liver transplantation (LTx) for patients with neuroendocrine tumors (NET) is a option for patients con metastasis limited to the liver.
The main indication is when the metastatic NET of the liver not accessible to surgery or reduction.
Conference: 15th Annual ENETS conference (2018)
Category: Case reports
Presenting Author: Physicians Juan Carlos Percovich
Authors: